Authors: Gobbi, PG Ghirardelli, ML Solcia, M Di Giulio, G Merli, F Tavecchia, L Berte, R Davini, O Levis, A Broglia, C Maffe, GC Ilariucci, F Dore, R Ascari, E

Citation: Pg. Gobbi et al., Image-aided estimate of tumor burden in Hodgkin's disease: Evidence of itsprimary prognostic importance, J CL ONCOL, 19(5), 2001, pp. 1388-1394

Authors: Sacchi, S Federico, M Vitolo, U Boccomini, C Vallisa, D Baldini, L Petrini, M Rupoli, S Di Raimondo, F Merli, F Liso, V Tabilio, A Saglio, G Vinci, G Brugiatelli, M Dastoli, G

Citation: S. Sacchi et al., Clinical activity and safety of combination immunotherapy with interferon-alpha 2a and rituximab in patients with relapsed low grade non-Hodgkin's lymphoma, HAEMATOLOG, 86(9), 2001, pp. 951-958

Authors: Bonci, A Di Lernia, V Merli, F Lo Scocco, G

Citation: A. Bonci et al., Erythema nodosum and Hodgkin's disease, CLIN EXP D, 26(5), 2001, pp. 408-411

Authors: Gobbi, PG Zinzani, PL Broglia, C Comelli, M Magagnoli, M Federico, M Merli, F Iannitto, E Tura, S Ascari, E

Citation: Pg. Gobbi et al., Comparison of prognostic models in patients with advanced Hodgkin disease - Promising results from integration of the best three systems, CANCER, 91(8), 2001, pp. 1467-1478

Authors: Stelitano, C Baldini, L Pieresca, C Callea, V Angrilli, F Clo, V Partesotti, G Merli, F Cavanna, L Morabito, F Federico, M Brugiatelli, M Silingardi, V

Citation: C. Stelitano et al., Validation of the International Prognostic Index in Working Formulation group A low-grade non-Hodgkin's lymphoma: retrospective analysis of 137 patients from the Gruppo Italiano per lo Studio dei Linfomi registry, HAEMATOLOG, 85(2), 2000, pp. 154-159

Authors: Menichini, E Monfredini, F Merli, F

Citation: E. Menichini et al., The temporal variability of the profile of carcinogenic polycyclic aromatic hydrocarbons in urban air: a study in a medium traffic area in Rome, 1993-1998, ATMOS ENVIR, 33(23), 1999, pp. 3739-3750